neural crest tumors

Unraveling ROHHAD-NET Syndrome: Clinical Insights and the Role of Anti-ZSCAN1 Antibodies in Diagnosis and Management

This nationwide Japanese study elucidates early clinical features of ROHHAD-NET syndrome and highlights anti-ZSCAN1 antibody titers as potential biomarkers linked to neural crest tumors and treatment response.